CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-18 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 111,290 | ||
| 2022-04-18 | Douglas Robert Andrew President and COO | Option exercise | +8,000 | $58.24 | $466K | 25,175 |
| 2022-04-18 | Douglas Robert Andrew President and COO | Sale | −8,000 | $233.29 | $1.9M | 17,175 |
| 2022-04-18 | Douglas Robert Andrew President and COO | Option exercise · ResMed Common Stock Options | −8,000 | 54,098 | ||
| 2022-04-11 | Sandercock Brett Chief Financial Officer | Option exercise | +2,500 | $57.76 | $144K | 108,854 |
| 2022-04-11 | Sandercock Brett Chief Financial Officer | Sale | −2,500 | $247.00 | $618K | 106,354 |
| 2022-04-11 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 10,000 | ||
| 2022-04-04 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,544 | $246.60 | $381K | 111,403 |
Page 28 of 28 · 548 trades